{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer's disease", "cuproptosis", "diagnostic", "drug", "immune"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36776574", "DateRevised": {"Year": "2023", "Month": "02", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "26"}], "Language": ["eng"], "ELocationID": ["1064639", "10.3389/fneur.2022.1064639"], "Journal": {"ISSN": "1664-2295", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in neurology", "ISOAbbreviation": "Front Neurol"}, "ArticleTitle": "Diagnostic models and predictive drugs associated with cuproptosis hub genes in Alzheimer's disease.", "Pagination": {"StartPage": "1064639", "MedlinePgn": "1064639"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a chronic neurodegenerative disease, and its underlying genes and treatments are unclear. Abnormalities in copper metabolism can prevent the clearance of \u03b2-amyloid peptides and promote the progression of AD pathogenesis. Therefore, the present study used a bioinformatics approach to perform an integrated analysis of the hub gene based on cuproptosis that can influence the diagnosis and treatment of AD. The gene expression profiles were obtained from the Gene Expression Omnibus database, including non-demented (ND) and AD samples. A total of 2,977 cuproptosis genes were retrieved from published articles. The seven hub genes associated with cuproptosis and AD were obtained from the differentially expressed genes and WGCNA in brain tissue from GSE33000. The GO analysis demonstrated that these genes were involved in phosphoribosyl pyrophosphate, lipid, and glucose metabolism. By stepwise regression and logistic regression analysis, we screened four of the seven cuproptosis genes to construct a diagnostic model for AD, which was validated by GES15222, GS48350, and GSE5281. In addition, immune cell infiltration of samples was investigated for correlation with these hub genes. We identified six drugs targeting these seven cuproptosis genes in DrugBank. Hence, these cuproptosis gene signatures may be an important prognostic indicator for AD and may offer new insights into treatment options."], "CopyrightInformation": "Copyright \u00a9 2023 Zhang, Dai, Chen, Liu, Xiao and Shen."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Optimal Utilization of Natural Medicinal Resources, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Zhang", "ForeName": "Erdong", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Dai", "ForeName": "Fengqiu", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guiyang Maternal and Child Health-Care Hospital, Guiyang, Guizhou, China."}], "LastName": "Chen", "ForeName": "Tingting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Institute of Urology, Lanzhou University Second Hospital, Lanzhou, Gansu, China."}], "LastName": "Liu", "ForeName": "Shanhui", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy, School of Basic Medical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Xiao", "ForeName": "Chaolun", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou, China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Optimal Utilization of Natural Medicinal Resources, Guizhou Medical University, Guiyang, Guizhou, China."}], "LastName": "Shen", "ForeName": "Xiangchun", "Initials": "X"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Neurol", "NlmUniqueID": "101546899", "ISSNLinking": "1664-2295"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Scheltens P, Strooper BD, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. . Alzheimer's disease. Lancet. (2021) 397:1577\u201390. 10.1016/S0140-6736(20)32205-4", "ArticleIdList": ["10.1016/S0140-6736(20)32205-4", "PMC8354300", "33667416"]}, {"Citation": "Rajan KB, Weuve J, Barnes LL, McAninch EA, Wilson RS, Evans DA. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060). Alzheimers Dement. (2021) 17:1966\u201375. 10.1002/alz.12362", "ArticleIdList": ["10.1002/alz.12362", "PMC9013315", "34043283"]}, {"Citation": "Alzheimer's disease facts and figures . Alzheimers Dement. (2022) 18:700\u201389. 10.1002/alz.12638", "ArticleIdList": ["10.1002/alz.12638", "35289055"]}, {"Citation": "Tanzi RE, Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell. (2005) 120:545\u201355. 10.1016/j.cell.2005.02.008", "ArticleIdList": ["10.1016/j.cell.2005.02.008", "15734686"]}, {"Citation": "Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. . Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. (2001) 293:1487\u201391. 10.1126/science.1058189", "ArticleIdList": ["10.1126/science.1058189", "11520987"]}, {"Citation": "Masters CL, Selkoe DJ. Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb Perspect Med. (2012) 2:a006262. 10.1101/cshperspect.a006262", "ArticleIdList": ["10.1101/cshperspect.a006262", "PMC3367542", "22675658"]}, {"Citation": "Benilova I, Karran E, De Strooper B. The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci. (2012) 15:349\u201357. 10.1038/nn.3028", "ArticleIdList": ["10.1038/nn.3028", "22286176"]}, {"Citation": "Zhu M, Wang X, Sun L, Schultzberg M, Hjorth E. Can inflammation be resolved in Alzheimer's disease? Ther Adv Neurol Disord. (2018) 11:1756286418791107. 10.1177/1756286418791107", "ArticleIdList": ["10.1177/1756286418791107", "PMC6088473", "30116300"]}, {"Citation": "Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis. (2000) 7:682\u20139. 10.1006/nbdi.2000.0321", "ArticleIdList": ["10.1006/nbdi.2000.0321", "11114266"]}, {"Citation": "Hu J, Akama KT, Krafft GA, Chromy BA, Van Eldik LJ. Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release. Brain Res. (1998) 785:195\u2013206. 10.1016/S0006-8993(97)01318-8", "ArticleIdList": ["10.1016/S0006-8993(97)01318-8", "9518610"]}, {"Citation": "DiSabato DJ, Quan N, Godbout JP. Neuroinflammation: the devil is in the details. J Neurochem. (2016) 139 Suppl 2:136\u201353. 10.1111/jnc.13607", "ArticleIdList": ["10.1111/jnc.13607", "PMC5025335", "26990767"]}, {"Citation": "Alves S, Churlaud G, Audrain M, Michaelsen-Preusse K, Fol R, Souchet B, et al. . Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice. Brain. (2017) 140:826\u201342. 10.1093/brain/aww330", "ArticleIdList": ["10.1093/brain/aww330", "28003243"]}, {"Citation": "Kiyota T, Okuyama S, Swan RJ, Jacobsen MT, Gendelman HE, Ikezu T, et al. . CNS expression of anti-inflammatory cytokine interleukin-4 attenuates Alzheimer's disease-like pathogenesis in APP+PS1 bigenic mice. FASEB J. (2010) 24:3093\u2013102. 10.1096/fj.10-155317", "ArticleIdList": ["10.1096/fj.10-155317", "PMC2909296", "20371618"]}, {"Citation": "Newcombe EA, Camats-Perna J, Silva ML, Valmas N, Huat TJ, Medeiros R. Inflammation: the link between comorbidities, genetics, and Alzheimer's disease. J Neuroinflammation. (2018) 15:276. 10.1186/s12974-018-1313-3", "ArticleIdList": ["10.1186/s12974-018-1313-3", "PMC6154824", "30249283"]}, {"Citation": "Roberts BR, Ryan TM, Bush AI, Masters CL, Duce JA. The role of metallobiology and amyloid-\u03b2 peptides in Alzheimer's disease. J Neurochem. (2012) 120(Suppl 1):149\u201366. 10.1111/j.1471-4159.2011.07500.x", "ArticleIdList": ["10.1111/j.1471-4159.2011.07500.x", "22121980"]}, {"Citation": "Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. (2004) 3:205\u201314. 10.1038/nrd1330", "ArticleIdList": ["10.1038/nrd1330", "15031734"]}, {"Citation": "Scheiber IF, Mercer JFB, Dringen R. Metabolism and functions of copper in brain. Prog Neurobiol. (2014) 116:33\u201357. 10.1016/j.pneurobio.2014.01.002", "ArticleIdList": ["10.1016/j.pneurobio.2014.01.002", "24440710"]}, {"Citation": "Mercer SW, Wang J, Burke R. In vivo modeling of the pathogenic effect of copper transporter mutations that cause Menkes and Wilson Diseases, motor neuropathy, and susceptibility to Alzheimer's disease. J Biol Chem. (2017) 292:4113\u201322. 10.1074/jbc.M116.756163", "ArticleIdList": ["10.1074/jbc.M116.756163", "PMC5354492", "28119449"]}, {"Citation": "Ayton S, Lei P, Bush AI. Metallostasis in Alzheimer's disease. Free Radic Biol Med. (2013) 62:76\u201389. 10.1016/j.freeradbiomed.2012.10.558", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.10.558", "23142767"]}, {"Citation": "White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, et al. . Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. (1999) 842:439\u201344. 10.1016/S0006-8993(99)01861-2", "ArticleIdList": ["10.1016/S0006-8993(99)01861-2", "10526140"]}, {"Citation": "Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, et al. . Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron. J Biol Chem. (2002) 277:44670\u20136. 10.1074/jbc.M204379200", "ArticleIdList": ["10.1074/jbc.M204379200", "12215434"]}, {"Citation": "Ma QF, Li YM, Du JT, Kanazawa K, Nemoto T, Nakanishi H, et al. . Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR. Biopolymers. (2005) 79:74\u201385. 10.1002/bip.20335", "ArticleIdList": ["10.1002/bip.20335", "15986501"]}, {"Citation": "Zhou L-X, Du J-T, Zeng Z-Y, Wu W-H, Zhao Y-F, Kanazawa K, et al. . Copper (II) modulates in vitro aggregation of a tau peptide. Peptides. (2007) 28:2229\u201334. 10.1016/j.peptides.2007.08.022", "ArticleIdList": ["10.1016/j.peptides.2007.08.022", "17919778"]}, {"Citation": "Scali C, Prosperi C, Bracco L, Piccini C, Baronti R, Ginestroni A, et al. . Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease. Neurobiol Aging. (2002) 23:523\u201330. 10.1016/S0197-4580(01)00346-3", "ArticleIdList": ["10.1016/S0197-4580(01)00346-3", "12009501"]}, {"Citation": "Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, et al. . Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med. (2015) 21:880\u20136. 10.1038/nm.3913", "ArticleIdList": ["10.1038/nm.3913", "26214837"]}, {"Citation": "Stock AJ, Kasus-Jacobi A, Pereira HA. The role of neutrophil granule proteins in neuroinflammation and Alzheimer's disease. J Neuroinflammation. (2018) 15:240. 10.1186/s12974-018-1284-4", "ArticleIdList": ["10.1186/s12974-018-1284-4", "PMC6112130", "30149799"]}, {"Citation": "Crouch PJ, Hung LW, Adlard PA, Cortes M, Lal V, Filiz G, et al. . Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation. Proc Natl Acad Sci U S A. (2009) 106:381\u20136. 10.1073/pnas.0809057106", "ArticleIdList": ["10.1073/pnas.0809057106", "PMC2626711", "19122148"]}, {"Citation": "Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, et al. . Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. (2022) 375:1254\u201361. 10.1126/science.abf0529", "ArticleIdList": ["10.1126/science.abf0529", "PMC9273333", "35298263"]}, {"Citation": "Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. (2015) 43:e47. 10.1093/nar/gkv007", "ArticleIdList": ["10.1093/nar/gkv007", "PMC4402510", "25605792"]}, {"Citation": "Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. (2008) 9:559. 10.1186/1471-2105-9-559", "ArticleIdList": ["10.1186/1471-2105-9-559", "PMC2631488", "19114008"]}, {"Citation": "Tolles J, Meurer WJ. Logistic regression: relating patient characteristics to outcomes. JAMA. (2016) 316:533\u20134. 10.1001/jama.2016.7653", "ArticleIdList": ["10.1001/jama.2016.7653", "27483067"]}, {"Citation": "Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, et al. . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. (2015) 12:453\u20137. 10.1038/nmeth.3337", "ArticleIdList": ["10.1038/nmeth.3337", "PMC4739640", "25822800"]}, {"Citation": "Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. . DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. (2018) 46:D1074\u201382. 10.1093/nar/gkx1037", "ArticleIdList": ["10.1093/nar/gkx1037", "PMC5753335", "29126136"]}, {"Citation": "Finaurini S, Basilico N, Corbett Y, D'Alessandro S, Parapini S, Olliaro P, et al. . Dihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle. Toxicology. (2012) 300:57\u201366. 10.1016/j.tox.2012.05.024", "ArticleIdList": ["10.1016/j.tox.2012.05.024", "22677887"]}, {"Citation": "Overington JP, Al-Lazikani B, Hopkins AL. How many drug targets are there? Nat Rev Drug Discov. (2006) 5:993\u20136. 10.1038/nrd2199", "ArticleIdList": ["10.1038/nrd2199", "17139284"]}, {"Citation": "Imming P, Sinning C, Meyer A. Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. (2006) 5:821\u201334. 10.1038/nrd2132", "ArticleIdList": ["10.1038/nrd2132", "17016423"]}, {"Citation": "Lee YC, Park CK, Kim MS, Kim JH. In vitro study for staining and toxicity of rose bengal on cultured bovine corneal endothelial cells. Cornea. (1996) 15:376\u201385. 10.1097/00003226-199607000-00008", "ArticleIdList": ["10.1097/00003226-199607000-00008", "8776564"]}, {"Citation": "Tana C, Ticinesi A, Prati B, Nouvenne A, Meschi T. Uric acid and cognitive function in older individuals. Nutrients. (2018) 10:975. 10.3390/nu10080975", "ArticleIdList": ["10.3390/nu10080975", "PMC6115794", "30060474"]}, {"Citation": "Strosznajder AK, W\u00f3jtowicz S, Jezyna MJ, Sun GY, Strosznajder JB. Recent insights on the role of PPAR-\u03b2/\u03b4 in neuroinflammation and neurodegeneration, and its potential target for therapy. Neuromolecular Med. (2021) 23:86\u201398. 10.1007/s12017-020-08629-9", "ArticleIdList": ["10.1007/s12017-020-08629-9", "PMC7929960", "33210212"]}, {"Citation": "Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, et al. . Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer's disease. Acta Neuropathol. (2021) 141:681\u201396. 10.1007/s00401-021-02263-w", "ArticleIdList": ["10.1007/s00401-021-02263-w", "PMC8043951", "33609158"]}, {"Citation": "West LC, Cresswell P. Expanding roles for GILT in immunity. Curr Opin Immunol. (2013) 25:103\u20138. 10.1016/j.coi.2012.11.006", "ArticleIdList": ["10.1016/j.coi.2012.11.006", "PMC4287230", "23246037"]}, {"Citation": "Satoh J-I, Kino Y, Yanaizu M, Ishida T, Saito Y. Microglia express gamma-interferon-inducible lysosomal thiol reductase in the brains of Alzheimer's disease and Nasu-Hakola disease. Intractable Rare Dis Res. (2018) 7:251\u20137. 10.5582/irdr.2018.01119", "ArticleIdList": ["10.5582/irdr.2018.01119", "PMC6290847", "30560017"]}, {"Citation": "Chai K, Zhang X, Chen S, Gu H, Tang H, Cao P, et al. . Application of weighted co-expression network analysis and machine learning to identify the pathological mechanism of Alzheimer's disease. Front Aging Neurosci. (2022) 14:837770. 10.3389/fnagi.2022.837770", "ArticleIdList": ["10.3389/fnagi.2022.837770", "PMC9326231", "35912089"]}, {"Citation": "Di Paolo G, Kim T-W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat Rev Neurosci. (2011) 12:284\u201396. 10.1038/nrn3012", "ArticleIdList": ["10.1038/nrn3012", "PMC3321383", "21448224"]}, {"Citation": "Penke B, Paragi G, Gera J, Berkecz R, Kov\u00e1cs Z, Crul T, et al. . The role of lipids and membranes in the pathogenesis of Alzheimer's disease: a comprehensive view. Curr Alzheimer Res. (2018) 15:1191\u2013212. 10.2174/1567205015666180911151716", "ArticleIdList": ["10.2174/1567205015666180911151716", "30207230"]}, {"Citation": "Ylilauri MPT, Voutilainen S, L\u00f6nnroos E, Virtanen HEK, Tuomainen T-P, Salonen JT, et al. . Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. (2019) 110:1416\u201323. 10.1093/ajcn/nqz148", "ArticleIdList": ["10.1093/ajcn/nqz148", "31360988"]}, {"Citation": "Semba RD. Perspective: the potential role of circulating lysophosphatidylcholine in neuroprotection against Alzheimer disease. Adv Nutr. (2020) 11:760\u201372. 10.1093/advances/nmaa024", "ArticleIdList": ["10.1093/advances/nmaa024", "PMC7360459", "32190891"]}, {"Citation": "Peters-Golden M, Brock TG. 5-lipoxygenase and FLAP. Prostaglandins Leukot Essent Fatty Acids. (2003) 69:99\u2013109. 10.1016/S0952-3278(03)00070-X", "ArticleIdList": ["10.1016/S0952-3278(03)00070-X", "12895592"]}, {"Citation": "Chu J, Pratic\u00f2 D. Involvement of 5-lipoxygenase activating protein in the amyloidotic phenotype of an Alzheimer's disease mouse model. J Neuroinflammation. (2012) 9:127. 10.1186/1742-2094-9-127", "ArticleIdList": ["10.1186/1742-2094-9-127", "PMC3425138", "22697885"]}, {"Citation": "Chu J, Lauretti E, Di Meco A, Pratic\u00f2 D. FLAP pharmacological blockade modulates metabolism of endogenous tau in vivo. Transl Psychiatry. (2013) 3:e333. 10.1038/tp.2013.106", "ArticleIdList": ["10.1038/tp.2013.106", "PMC4030325", "24301651"]}, {"Citation": "Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. . Microglial activation and tau propagate jointly across Braak stages. Nat Med. (2021) 27:1592\u20139. 10.1038/s41591-021-01456-w", "ArticleIdList": ["10.1038/s41591-021-01456-w", "34446931"]}, {"Citation": "Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, et al. . Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. (2016) 139:1237\u201351. 10.1093/brain/awv408", "ArticleIdList": ["10.1093/brain/awv408", "26912648"]}, {"Citation": "Katayama H. Anti-interleukin-17A and anti-interleukin-23 antibodies may be effective against Alzheimer's disease: role of neutrophils in the pathogenesis. Brain Behav. (2020) 10:e01504. 10.1002/brb3.1504", "ArticleIdList": ["10.1002/brb3.1504", "PMC6955921", "31849180"]}, {"Citation": "Carlini V, Verduci I, Cianci F, Cannavale G, Fenoglio C, Galimberti D, et al. . CLIC1 protein accumulates in circulating monocyte membrane during neurodegeneration. Int J Mol Sci. (2020) 21:E1484. 10.3390/ijms21041484", "ArticleIdList": ["10.3390/ijms21041484", "PMC7073046", "32098256"]}, {"Citation": "Sandin L, Bergkvist L, Nath S, Kielkopf C, Janefjord C, Helmfors L, et al. . Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster. FEBS J. (2016) 283:3508\u201322. 10.1111/febs.13830", "ArticleIdList": ["10.1111/febs.13830", "PMC5132093", "27562772"]}, {"Citation": "Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, et al. . Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease. Nat Commun. (2022) 13:159. 10.1038/s41467-021-27572-2", "ArticleIdList": ["10.1038/s41467-021-27572-2", "PMC8748865", "35013160"]}, {"Citation": "Gaggelli E, Kozlowski H, Valensin D, Valensin G. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem Rev. (2006) 106:1995\u20132044. 10.1021/cr040410w", "ArticleIdList": ["10.1021/cr040410w", "16771441"]}, {"Citation": "Zhao Y, Long Z, Liu Y, Luo M, Qiu Y, Idris NFB, et al. . Dihydroartemisinin ameliorates decreased neuroplasticity-associated proteins and excessive neuronal apoptosis in APP/PS1 mice. Curr Alzheimer Res. (2020) 17:916\u2013925. 10.2174/1567205017666201215124746", "ArticleIdList": ["10.2174/1567205017666201215124746", "33327914"]}, {"Citation": "Xia L, Pang Y, Li J, Wu B, Du Y, Chen Y, et al. . Dihydroartemisinin induces O-GlcNAcylation and improves cognitive function in a mouse model of tauopathy. J Alzheimers Dis. (2021) 84:239\u201348. 10.3233/JAD-210643", "ArticleIdList": ["10.3233/JAD-210643", "34511503"]}, {"Citation": "Gao Y, Cui M, Zhong S, Feng C, Nwobodo AK, Chen B, et al. . Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K/AKT pathway. Metab Brain Dis. (2020) 35:661\u201372. 10.1007/s11011-020-00533-2", "ArticleIdList": ["10.1007/s11011-020-00533-2", "32152798"]}, {"Citation": "Cao D, Lu H, Lewis TL Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease *. J Biol Chem. (2007) 282:36275\u201382. 10.1074/jbc.M703561200", "ArticleIdList": ["10.1074/jbc.M703561200", "17942401"]}, {"Citation": "Chen PE, Geballe MT, Stansfeld PJ, Johnston AR, Yuan H, Jacob AL, et al. . Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Mol Pharmacol. (2005) 67:1470\u201384. 10.1124/mol.104.008185", "ArticleIdList": ["10.1124/mol.104.008185", "15703381"]}, {"Citation": "Kreamer BL, Siegel FL, Gourley GR. A novel inhibitor of beta-glucuronidase: L-aspartic acid. Pediatr Res. (2001) 50:460\u20136. 10.1203/00006450-200110000-00007", "ArticleIdList": ["10.1203/00006450-200110000-00007", "11568288"]}, {"Citation": "Qin J, Kunda N, Qiao G, Calata JF, Pardiwala K, Prabhakar BS, et al. . Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death. Cell Death Dis. (2017) 8:e2584. 10.1038/cddis.2016.473", "ArticleIdList": ["10.1038/cddis.2016.473", "PMC5386459", "28151483"]}, {"Citation": "Lee JS, Lee BI, Park CB. Photo-induced inhibition of Alzheimer's \u03b2-amyloid aggregation in vitro by rose bengal. Biomaterials. (2015) 38:43\u20139. 10.1016/j.biomaterials.2014.10.058", "ArticleIdList": ["10.1016/j.biomaterials.2014.10.058", "25457982"]}, {"Citation": "Dubey T, Gorantla NV, Chandrashekara KT, Chinnathambi S. Photodynamic exposure of Rose-Bengal inhibits Tau aggregation and modulates cytoskeletal network in neuronal cells. Sci Rep. (2020) 10:12380. 10.1038/s41598-020-69403-2", "ArticleIdList": ["10.1038/s41598-020-69403-2", "PMC7378248", "32704015"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "8"}, {"Year": "2022", "Month": "12", "Day": "29"}, {"Year": "2023", "Month": "2", "Day": "13", "Hour": "3", "Minute": "21"}, {"Year": "2023", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "1", "Day": "26"}], "PublicationStatus": "epublish", "ArticleIdList": ["36776574", "PMC9909238", "10.3389/fneur.2022.1064639"]}}], "PubmedBookArticle": []}